Congress trades and big insider sales, sent the day they're filed. Free.
Open in TelegramOfficers, directors and 10% owners must report trades within two business days on SEC Form 4. INSIDER parses each filing's XML from EDGAR. By default only discretionary open-market purchases and sales are shown; grants, option exercises and tax withholding are one click away.
Kurtz George0B / 239S · 10 late239 trades$59.22M
Wilhelmsen Arne Alexander0B / 47S47 trades$241.96M| Score | Actor | Security | Side | Value | Disclosed | Evidence |
|---|---|---|---|---|---|---|
| 20 | Clifford Katherine LeeChief Leadership & HR Officer | ACNAccenture plc Open-market sale · 10b5-1 plan | SELL | $145K 514 sh |
| Jan 27, 2026 traded Jan 26, 2026 |
| 20 | Walsh John FCEO-The Americas | ACNAccenture plc Open-market sale · 10b5-1 plan | SELL | $3,360 12 sh | Jan 27, 2026 traded Jan 27, 2026 |
| 18 | Dube Eric MDirector, CHIEF EXECUTIVE OFFICER |  TVTXTravere Therapeutics, Inc.Open-market sale · 10b5-1 plan | SELL | $244K 8,135 sh | Jan 27, 2026 traded Jan 23, 2026 |
| 15 | Singh Ritadhwaja JebensEVP & CHIEF DIGITAL OFFICER |  LTHLife Time Group Holdings, Inc.Open-market sale · 10b5-1 plan | SELL | $360K 12.1K sh | Jan 27, 2026 traded Jan 23, 2026 |
| 13 | Clifford Katherine LeeChief Leadership & HR Officer | ACNAccenture plc Open-market sale · 10b5-1 plan | SELL | $20K 71 sh | Jan 27, 2026 traded Jan 26, 2026 |
| 13 | Clifford Katherine LeeChief Leadership & HR Officer | ACNAccenture plc Open-market sale · 10b5-1 plan | SELL | $47K 168 sh | Jan 27, 2026 traded Jan 26, 2026 |
| 13 | Clifford Katherine LeeChief Leadership & HR Officer | ACNAccenture plc Open-market sale · 10b5-1 plan | SELL | $567 2 sh | Jan 27, 2026 traded Jan 26, 2026 |
| 13 | Clifford Katherine LeeChief Leadership & HR Officer | ACNAccenture plc Open-market sale · 10b5-1 plan | SELL | $8,904 32 sh | Jan 27, 2026 traded Jan 26, 2026 |
| 9 | Cannon-Brookes MichaelDirector, CEO, Co-Founder, 10% Owner | TEAMAtlassian Corp Open-market sale · 10b5-1 plan | SELL | $270K 1,988 sh | Jan 27, 2026 traded Jan 26, 2026 |
| 9 | Cannon-Brookes MichaelDirector, CEO, Co-Founder, 10% Owner | TEAMAtlassian Corp Open-market sale · 10b5-1 plan | SELL | $265K 1,913 sh | Jan 27, 2026 traded Jan 26, 2026 |
| 9 |  Farquhar ScottDirector, 10% Owner | TEAMAtlassian Corp Open-market sale · 10b5-1 plan | SELL | $270K 1,987 sh | Jan 27, 2026 traded Jan 26, 2026 |
| 9 | Farquhar ScottDirector, 10% Owner | TEAMAtlassian Corp Open-market sale · 10b5-1 plan | SELL | $265K 1,914 sh | Jan 27, 2026 traded Jan 26, 2026 |
| 9 | Farquhar ScottDirector, 10% Owner | TEAMAtlassian Corp Open-market sale · 10b5-1 plan | SELL | $364K 2,664 sh | Jan 27, 2026 traded Jan 26, 2026 |
| 9 | Cannon-Brookes MichaelDirector, CEO, Co-Founder, 10% Owner | TEAMAtlassian Corp Open-market sale · 10b5-1 plan | SELL | $364K 2,663 sh | Jan 27, 2026 traded Jan 26, 2026 |
| 6 | Cannon-Brookes MichaelDirector, CEO, Co-Founder, 10% Owner | TEAMAtlassian Corp Open-market sale · 10b5-1 plan | SELL | $131K 951 sh | Jan 27, 2026 traded Jan 26, 2026 |
| 6 | Farquhar ScottDirector, 10% Owner | TEAMAtlassian Corp Open-market sale · 10b5-1 plan | SELL | $131K 950 sh | Jan 27, 2026 traded Jan 26, 2026 |
| 3 | Cannon-Brookes MichaelDirector, CEO, Co-Founder, 10% Owner | TEAMAtlassian Corp Open-market sale · 10b5-1 plan | SELL | $13K 100 sh | Jan 27, 2026 traded Jan 26, 2026 |
| 3 | Farquhar ScottDirector, 10% Owner | TEAMAtlassian Corp Open-market sale · 10b5-1 plan | SELL | $6,652 50 sh | Jan 27, 2026 traded Jan 26, 2026 |
| 3 | Farquhar ScottDirector, 10% Owner | TEAMAtlassian Corp Open-market sale · 10b5-1 plan | SELL | $13K 100 sh | Jan 27, 2026 traded Jan 26, 2026 |
| 3 | Cannon-Brookes MichaelDirector, CEO, Co-Founder, 10% Owner | TEAMAtlassian Corp Open-market sale · 10b5-1 plan | SELL | $6,652 50 sh | Jan 27, 2026 traded Jan 26, 2026 |
| 62 | Rooney Robert GeraldDirector | NONETCW Private Asset Income Fund Open-market purchase | BUY | $281K 28.1K sh | Jan 26, 2026 traded Nov 10, 2025 |
| 59 | Rooney Robert GeraldDirector | NONETCW Private Asset Income Fund Open-market purchase | BUY | $113K 11.3K sh | Jan 26, 2026 traded Nov 10, 2025 |
| 41 | Cheng LawrenceDirector |  GMEGameStop Corp.Open-market purchase | BUY | $114K 5,000 sh | Jan 26, 2026 traded Jan 23, 2026 |
| 35 | Schwab-Pomerantz CarolynDirector |  SCHWSCHWAB CHARLES CORPOpen-market sale | SELL | $1.00M 9,525 sh | Jan 26, 2026 traded Jan 22, 2026 |
| 35 | Bhatia Manish HEVP, Global Operations |  MUMICRON TECHNOLOGY INCOpen-market sale | SELL | $2.81M 7,200 sh | Jan 26, 2026 traded Jan 22, 2026 |
| 35 | Schwab-Pomerantz CarolynDirector | SCHWSCHWAB CHARLES CORP Open-market sale | SELL | $2.00M 19.1K sh | Jan 26, 2026 traded Jan 22, 2026 |
| 35 | Schwab-Pomerantz CarolynDirector | SCHWSCHWAB CHARLES CORP Open-market sale | SELL | $1.00M 9,525 sh | Jan 26, 2026 traded Jan 22, 2026 |
| 35 | Bhatia Manish HEVP, Global Operations | MUMICRON TECHNOLOGY INC Open-market sale | SELL | $1.99M 5,128 sh | Jan 26, 2026 traded Jan 22, 2026 |
| 35 | Bhatia Manish HEVP, Global Operations | MUMICRON TECHNOLOGY INC Open-market sale | SELL | $3.32M 8,500 sh | Jan 26, 2026 traded Jan 22, 2026 |
| 33 | Sibold William JohnDirector, President and CEO |  MDGLMADRIGAL PHARMACEUTICALS, INC.Open-market sale | SELL | $777K 1,577 sh | Jan 26, 2026 traded Jan 26, 2026 |
| 33 | Tpg Gp A, Llc10% Owner |  SIONSionna Therapeutics, Inc.Open-market sale | SELL | $10.00M 250.0K sh | Jan 26, 2026 traded Jan 22, 2026 |
| 32 | Bhatia Manish HEVP, Global Operations | MUMICRON TECHNOLOGY INC Open-market sale | SELL | $911K 2,300 sh | Jan 26, 2026 traded Jan 22, 2026 |
| 32 | Schwab-Pomerantz CarolynDirector | SCHWSCHWAB CHARLES CORP Open-market sale | SELL | $500K 4,765 sh | Jan 26, 2026 traded Jan 22, 2026 |
| 32 | Wilson Kelli AnnEVP Chief Banking Officer |  HFWAHERITAGE FINANCIAL CORP /WA/Open-market sale | SELL | $50K 1,900 sh | Jan 26, 2026 traded Jan 26, 2026 |
| 32 | Bhatia Manish HEVP, Global Operations | MUMICRON TECHNOLOGY INC Open-market sale | SELL | $864K 2,200 sh | Jan 26, 2026 traded Jan 22, 2026 |
| 32 | Bhatia Manish HEVP, Global Operations | MUMICRON TECHNOLOGY INC Open-market sale | SELL | $511K 1,295 sh | Jan 26, 2026 traded Jan 22, 2026 |
| 30 | Taub RebeccaDirector | MDGLMADRIGAL PHARMACEUTICALS, INC. Open-market sale | SELL | $319K 647 sh | Jan 26, 2026 traded Jan 26, 2026 |
| 29 | Beckwith Van H.EVP, Secretary and CLO |  HALHALLIBURTON COOpen-market sale · 10b5-1 plan | SELL | $1.90M 54.3K sh | Jan 26, 2026 traded Jan 23, 2026 |
| 27 | O'Day Daniel PatrickDirector, Chairman & CEO |  GILDGILEAD SCIENCES, INC.Open-market sale · 10b5-1 plan | SELL | $15.61M 115.6K sh | Jan 26, 2026 traded Jan 23, 2026 |
| 25 | Huntsman CaroleChief Commercial Officer | MDGLMADRIGAL PHARMACEUTICALS, INC. Open-market sale · 10b5-1 plan | SELL | $282K 570 sh | Jan 26, 2026 traded Jan 26, 2026 |
